[go: up one dir, main page]

WO1999054353A3 - Menschliche nukleinsäuresequenzen aus uterusnormalgewebe - Google Patents

Menschliche nukleinsäuresequenzen aus uterusnormalgewebe Download PDF

Info

Publication number
WO1999054353A3
WO1999054353A3 PCT/DE1999/001175 DE9901175W WO9954353A3 WO 1999054353 A3 WO1999054353 A3 WO 1999054353A3 DE 9901175 W DE9901175 W DE 9901175W WO 9954353 A3 WO9954353 A3 WO 9954353A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
human nucleic
normal uterus
uterus tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/001175
Other languages
English (en)
French (fr)
Other versions
WO1999054353A2 (de
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Original Assignee
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH filed Critical METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority to JP2000544691A priority Critical patent/JP2002512017A/ja
Priority to EP99924793A priority patent/EP1071777A2/de
Publication of WO1999054353A2 publication Critical patent/WO1999054353A2/de
Publication of WO1999054353A3 publication Critical patent/WO1999054353A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Es werden menschliche Nukleinsäuresequenzen - mRNA, cDNA, genomische Sequenzen - aus Uterusnormalgewebe, die für Genprodukte oder Teile davon kodieren, und deren Verwendung beschrieben. Es werden weiterhin die über die Sequenzen erhältlichen Polypeptide und deren Verwendung beschrieben.
PCT/DE1999/001175 1998-04-17 1999-04-15 Menschliche nukleinsäuresequenzen aus uterusnormalgewebe Ceased WO1999054353A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000544691A JP2002512017A (ja) 1998-04-17 1999-04-15 正常子宮組織からのヒト核酸配列
EP99924793A EP1071777A2 (de) 1998-04-17 1999-04-15 Menschliche nukleinsäuresequenzen aus uterusnormalgewebe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19817946.4 1998-04-17
DE19817946A DE19817946A1 (de) 1998-04-17 1998-04-17 Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe

Publications (2)

Publication Number Publication Date
WO1999054353A2 WO1999054353A2 (de) 1999-10-28
WO1999054353A3 true WO1999054353A3 (de) 2000-07-20

Family

ID=7865424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001175 Ceased WO1999054353A2 (de) 1998-04-17 1999-04-15 Menschliche nukleinsäuresequenzen aus uterusnormalgewebe

Country Status (4)

Country Link
EP (1) EP1071777A2 (de)
JP (1) JP2002512017A (de)
DE (1) DE19817946A1 (de)
WO (1) WO1999054353A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372473B1 (en) 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
AU2002301608C1 (en) * 1998-03-10 2005-08-11 Genentech, Inc. Novel PRO351 Polypeptides and Nucleic Acids Encoding Same
NZ525914A (en) * 1998-03-10 2004-03-26 Genentech Inc Novel polypeptides and nucleic acids encoding the same
US7723488B2 (en) 1998-03-27 2010-05-25 Genentech, Inc. Monoclonal antibodies to secreted and transmembrane polypeptides
DE69939989D1 (de) * 1998-04-22 2009-01-08 Genentech Inc Menschliches gas-6 (growth arrest-specific gene 6) Protein und dafür kodierende Nukleinsäuren
AU2224800A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
ATE402953T1 (de) * 1999-10-18 2008-08-15 Lexicon Pharmaceuticals Inc Menschliches chordin und polynukleotiden die dafür kodieren
EP1230359A1 (de) * 1999-11-10 2002-08-14 Compugen Ltd. Chordin-ähnliche homologe
AU4196801A (en) * 2000-03-02 2001-09-12 Amgen Inc Chordin-like-2 molecules and uses thereof
WO2001092306A2 (en) 2000-05-31 2001-12-06 Genzyme Corporation Therapeutic compounds for ovarian cancer
EP1330543A4 (de) * 2000-10-02 2006-03-29 Bayer Ag In krebsgewebe differenziert exprimierte nukleinsäuresequenzen
AU2002232563A1 (en) * 2001-12-05 2003-06-23 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
GB0216727D0 (en) 2002-07-17 2002-08-28 Univ Cambridge Tech Genes
WO2005117968A2 (en) 2004-04-14 2005-12-15 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development
AU2010245739B2 (en) 2009-05-08 2013-07-11 Genentech, Inc. Humanized anti-EGFL7 antibodies and methods using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024655A1 (en) * 1992-05-27 1993-12-09 Amersham International Plc Rna analysis
WO1999055858A2 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Für Genomforschung Mbh Menschliche nukleinsäuresequenzen aus pankreastumorgewebe

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024655A1 (en) * 1992-05-27 1993-12-09 Amersham International Plc Rna analysis
WO1999055858A2 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Für Genomforschung Mbh Menschliche nukleinsäuresequenzen aus pankreastumorgewebe

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BONFIELD, J. ET AL.: "A new sequence assembly program", NUCLEIC ACIDS RESEARCH., vol. 23, 1995, pages 4992-9, XP002127627, ISSN: 0305-1048 *
CRESCENZI, E., ET AL.: "identification of differentially expressed mRNAs in normal and neoplastiic (adenocarcinoma) human endometrium", GYNECOLOGIC ONCOLOGY, vol. 63, November 1996 (1996-11-01), pages 228 - 233, XP000874036 *
FANNON M R: "Gene expression in normal and disease states - identification of therapeutic targets", TRENDS IN BIOTECHNOLOGY,GB,ELSEVIER PUBLICATIONS, CAMBRIDGE, vol. 14, no. 8, 1 August 1996 (1996-08-01), pages 294 - 298, XP004035748, ISSN: 0167-7799 *
HILLIER, L., ET AL.: "the WashU-Merck EST project - unpublished", EMBL SEQUENCE DATA LIBRARY, 7 September 1996 (1996-09-07), heidelberg, germany, XP002129529 *
HILLIER, L., ET AL.: "the WashU-Merck EST project 1997", EMBL SEQUENCE DATA LIBRARY, 11 June 1997 (1997-06-11), heidelberg, germany, XP002129531 *
HILLIER, L., ET AL.: "the WashU-Merck EST project 1997", EMBL SEQUENCE DATA LIBRARY, 14 May 1997 (1997-05-14), heidelberg, germany, XP002129530 *
JANSA,P., ET AL.: "cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes", THE EMBO JOURNAL, vol. 17, no. 10, 15 May 1998 (1998-05-15), pages 2855 - 2864, XP002129532 *
SCHMITT AO. ET AL.: "Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues.", NUCLEIC ACID RESEARCH, vol. 27, no. 21, November 1999 (1999-11-01), pages 4251 - 4260, XP002129533 *
SCHULER, G. D.: "Sequence mapping by electronic PCR", GENOME RESEARCH., vol. 7, 1997, pages 541 - 550, XP002127628, ISSN: 1088-9051 *
WANG, Y. AND MIKSICEK, R.J.: "characterization of estrogen receptor cDNAs of human uterus: identification of a novel PvuII polymorphism", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 101, 1994, pages 101 - 110, XP000874034 *

Also Published As

Publication number Publication date
DE19817946A1 (de) 1999-10-21
EP1071777A2 (de) 2001-01-31
WO1999054353A2 (de) 1999-10-28
JP2002512017A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
WO1999053051A3 (en) 5' ests and encoded human proteins
WO1999054460A3 (de) Menschliche nukleinsäuresequenzen aus normalem blasengewebe
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
WO1999055858A3 (de) Menschliche nukleinsäuresequenzen aus pankreastumorgewebe
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
CA2296769A1 (en) Modified dorsal tissue affecting factor and compositions
WO1999006548A3 (en) 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
EP1033401A3 (de) Exprimierte Sequenzmarker und kodierte menschliche Proteine
WO2002002624A3 (en) B7-like molecules and uses thereof
WO2002024891A3 (en) B7-like molecules and uses thereof
WO1999006554A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
ZA200007040B (en) Catalyst modifiers and their use in the polymerization of olefin(s).
WO1999006549A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO1999006439A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
WO1999006553A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2000053776A3 (en) Human kallikrein-like genes
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999047655A3 (de) Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999924793

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09647788

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999924793

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999924793

Country of ref document: EP